Atlas Trials

Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis

Clinical trial NCT00622687 · TERMINATED

Trial details

NCT number
NCT00622687
Sponsor
Charite University, Berlin, Germany
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Systemic Sclerosis
Start date
1997-09-01
Primary completion
2003-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.